<DOC>
	<DOCNO>NCT00821015</DOCNO>
	<brief_summary>Atrial fibrillation common disable irregular heart rhythm , affect 1 1.5 million Americans . Recent clinical experience Medtronic Arctic Front™ Cardiac CryoAblation Catheter System suggest use isolate pulmonary vein ( PVs ) safely effectively patient AF , thereby reduce eliminate recurrence AF.3-4 However , large ablative surface balloon ablation catheter raise possibility technique may damage extensive area atrial myocardium . The LA elastic chamber , design expand contract ease accommodate influx outflow blood , maintain relatively low pressure . When exposed stress injury , whether acute chronic , LA may lose much elasticity , result overall dilation accompany fibrosis case . Overall , may potentially result diminution LA mechanical function ( systolic contractile function , diastolic relaxation function ) . In addition , LA function link Left Ventricular ( LV ) systolic diastolic function , manifest overall impact cardiac remodeling , include area pulmonary vein ostia , significant decrease LV ejection fraction ( LVEF ) . On hand , positive effect maintain sinus rhythm successful catheter ablation AF may result improvement LA mechanical function.5-9 Based potentially deleterious effect damage cause cryoablation , atrial myocardium balloon ablation , prospective , non-randomized , single-center study design assess atrial effect balloon cryo-ablation .</brief_summary>
	<brief_title>Effect Balloon Cryoablation Left Atrial Function</brief_title>
	<detailed_description>This study prospective , non-randomized , single-center , control study patient AF refer ablation fail one Class I-IV antiarrhythmic drug use treatment AF . • All study subject undergo cryoablation . Subjects follow 12 month assess chronic impact ablation Medtronic CryoCath Arctic Front™ Cardiac CryoAblation Catheter System LA LV mechanical function . In addition , patient undergo schedule symptom-driven assessment detect recurrent AF adverse event ( AEs ) . We evaluate effect ablation Medtronic Arctic Front™ Cardiac CryoAblation Catheter System atrial myocardium , respect LA ( LV ) mechanical function , assess image acquire use TTE CT adult patient atrial fibrillation fail least one anti-arrhythmic drug . The efficacy Arctic Front™ Cardiac CryoAblation Catheter System assess ambulatory continuous ECG monitoring</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Documented paroxysmal atrial fibrillation ≥ 18 ≤ 85 year age Failure one AF Drugs ( AFDs ) . Referral pulmonary vein isolation catheter ablation procedure treat atrial fibrillation Ability understand requirement study Willingness adhere study restriction comply post procedural followup requirement Any reversible cause AF ( postsurgery , thyroid disorder , etc . ) More 4 cardioversions prior year . Patients recent myocardial infarction ( le 2 month ) unstable angina . Patients congestive heart failure ( NYHA class III IV ) . Patients experience cerebral ischemic event , include TIA precede 1 month . Women know pregnant positive βHCG test 7 day prior procedure . Patients significant uncontrolled unstable medical condition ( include uncontrolled clinically significant coagulation disorder ) . Patients whose life expectancy le one year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>cryoablation</keyword>
	<keyword>recur arrhythmia</keyword>
	<keyword>stroke</keyword>
	<keyword>RF ablation</keyword>
	<keyword>LA ablation</keyword>
	<keyword>nodal ablation</keyword>
	<keyword>catheter ablation</keyword>
</DOC>